.svg){kind=small}
Sep-2025
Sales
Trend
6-Month
Product Count
SKUs
Overview
Market Insights Snapshot
VET CBD has shown varied performance across different states and categories in recent months. In the Arizona market, the brand's presence in the Edible category has been inconsistent, with rankings fluctuating between 44th in June 2025 and 42nd in September 2025, but notably absent from the top 30 in August, indicating a challenging competitive landscape. Meanwhile, their performance in the Tincture & Sublingual category in Arizona was strong, securing the 4th position in July 2025, demonstrating a solid foothold in this category, although data for other months is not available, suggesting potential volatility or a strategic focus on specific months.
In California, VET CBD has maintained a consistent presence in the Tincture & Sublingual category, holding steady with a 4th place ranking in both June and August 2025, and improving to 3rd in July. This stability in California highlights the brand's strength and consumer loyalty in one of the largest cannabis markets. However, the absence of any ranking in the Edible category in California suggests that VET CBD may either not compete in this segment or faces significant competition that limits its visibility. The brand's ability to maintain and slightly improve its position in the Tincture & Sublingual category despite fluctuations in sales figures reflects a resilient strategy in a competitive market.
Competitive Landscape
In the highly competitive Tincture & Sublingual category in California, VET CBD consistently maintained a strong position, ranking 4th in June, August, and September 2025, and briefly climbing to 3rd in July 2025. This fluctuation in rank is notable as it reflects the brand's resilience amidst shifting market dynamics. Despite a dip in sales from July to September, VET CBD's rank remained stable, indicating a loyal customer base. In contrast, Papa & Barkley dominated the category, holding the top rank until September when it slipped to 2nd, while Care By Design consistently held the 3rd position, except in July when VET CBD overtook it. Meanwhile, ABX / AbsoluteXtracts and Proof showed upward momentum, with ABX rising to 5th and Proof to 6th by September. These competitive dynamics suggest that while VET CBD is a strong contender, continuous innovation and marketing efforts are crucial to maintain and improve its standing in this evolving market.
Notable Products
In September 2025, the top-performing product for VET CBD was the CBD/THC 20:1 Regular Strength Tincture (250mg CBD, 12.5mg THC, 60ml, 2oz), maintaining its number one rank from August with sales of 862 units. The CBD/THC 20:1 Regular Strength Tincture (125mg CBD, 6.25mg THC, 1oz, 30ml) held steady at the second position, showing consistent popularity. The CBD/THC 20:1 Regular Strength Tincture (1000mg CBD, 50mg THC, 2oz, 60ml) climbed to third place from fifth in August, indicating a positive trend in consumer preference. Meanwhile, the CBD/THC 20:1 Extra Strength Pet Tincture (250mg CBD, 25mg THC, 60ml, 2oz) dropped to fourth place, despite previously holding the third position for three consecutive months. Lastly, the CBD/THC 10:1 Extra Strength Tincture (500mg CBD, 50mg THC, 60ml, 2oz) remained in fifth place, showing stable sales figures compared to the previous month.
Top Selling Cannabis Brands
Data for this report comes from real-time sales reporting by participating cannabis retailers via their point-of-sale systems, which are linked up with Headset’s business intelligence software. Headset’s data is very reliable, as it comes digitally direct from our partner retailers. However, the potential does exist for misreporting in the instance of duplicates, incorrectly classified products, inaccurate entry of products into point-of-sale systems, or even simple human error at the point of purchase. Thus, there is a slight margin of error to consider. Brands listed on this page are ranked in the top twenty within the market and product category by total retail sales volume.
